Table 2 Participant characteristics.
Author, year | N | Sex N and (%) female | Age in years [mean ± SD or median (IQR)] | Osteoarthritis (type and severity if known) | Diagnosed depression | Other characteristics |
|---|---|---|---|---|---|---|
Ahn and Ham 202075 | 90 | 80 (88) | 71.3 ± 7.1 | OA (not specified) | No | 49% had hypertension, majority of participants were farmers |
Allen et al. 201985 | 248 | 122 (49) | 59.0 ± 10.3 | Hip/knee OA | No | None |
Barlow et al. 200076 | 544 | 168 (31) | I: 57.3 ± 13.2 C: 59.1 ± 12.3 | OA (not specified) | No | OA condition duration in years mean ± SD: I: 13.9 ± 10.6 C: 13.6 ± 9.1 Arthritis type: 104 OA, 70 RA, 25 other |
Broderick et al. 201486 | 256 | Not stated | I: 68.0 ± 8.7 C: 66.4 ± 10.3 | Hip/knee OA Knee (vs. hip), 81%; 73% (of sample) Arthritis severity (K-L grading; I, C): 0 to 1; 17%, 27% > 1 to 2; 27%, 21% > 2 to 3; 26%, 23% > 3 to 4; 30%, 30% | No | OA condition duration in years mean ± SD: I: 10.7 ± 11.2 C: 11.3 ± 10.9 15–16% were receiving treatment for a psychiatric disorder and 10% had memory/thinking problems |
Bossen et al. 201384 | 199 | 129 (65) | I: 61 ± 5.9 C: 63 ± 5.4 | Group: % of sample knee, hip, both OA I: 67%, 21%, 12% C: 60%, 20%, 19% | No | Number of comorbidities (I%, C%): None, (65, 60) One, (19, 16) Two or more, (16, 23) |
Cheung et al. 201770 | 83 | 70 (84) | I1: 68.9 ± 7.7 I2: 74.4 ± 7.5 C: 71.8 ± 8.0 | Knee OA | No | None |
Fransen et al. 200727 | 2152 | 112 (74) | I1: 70.0 ± 6.3 I2: 70.8 ± 6.3 C: 69.6 ± 6.1 | Hip/knee OA: % of sample for I1, I2, C Both knees: 74%, 61%, 80% Both hips: 20%, 29%, 29% Single knee: 93%, 73%, 88% Single hip joint: 7%, 27%, 12% | No | OA symptom duration: % of sample for I1, I2, C < 6 years: 31%, 46%, 22% 6–10 years: 35%, 27%, 46% > 10 years: 35%, 25%, 29% |
French et al. 201371 | 131 | 84 (64) | I1: 61.8 ± 9.7 I2: 64.8 ± 9.8 C: 60.8 ± 9.7 | Knee OA | No | Mean number of comorbidities: I1: 2, I2: 2.6, C: 1.86 |
Hausmann et al. 201787 | 42 | 7 (17) | 67.5 ± 10.3 | % of sample hip/knee/both OA 45%, 55%, 45% | 33% of participants had anxiety and 48% depression | Comorbidities mean ± SD: 3.7 ± 2.8 |
Helminem et al. 201588 | 111 | 77 (69) | I: 64.5 ± 7.3 C: 62.8 ± 7.2 | Knee OA | No | None |
Hurley et al. 200777 | 418 | 294 (70) | I: 68 (51–84) C: 67 (51–89) | Knee OA | No | OA symptom duration in years, median (IQR): I: 5 (3–11) C: 6 (3–5) |
Kuntz et al. 201834 | 31 | 31 (100) | I1: 65.5 ± 5.6 I2: 63.7 ± 9 C: 71.1 ± 9.3 | Knee OA | No | Comorbidities mean ± SD: I1: 2.1 ± 1.0 I2: 2.1 ± 1.7 C: 2.9 ± 1.4 |
Lin et al. 200389 | 1001 | 684 (68) | 72 ± 7.4 | Knee OA | Yes (N, %): Major depression: 159, 16 Dysthymia: 288, 29 | None |
Lin et al. 202072 | 80 | 41 (51) | I: 55.9 ± 15.8 C: 58.1 ± 16.9 | Knee OA | No | Comorbidity (N) Yes (52) No (28) |
Moonaz et al. 201535 | 75 | 72 (96) | 52 ± 12 | OA (not specified) | No | OA condition duration in years mean ± SD I: 9.9 ± 8.7 C:8.6 ± 9.4 |
O’Moore et al. 201890 | 69 | 55 (80) | I: 63.2 ± 7.4 C: 59.7 ± 6.0 | Knee OA | Yes. Major depressive disorder | None |
Park et al. 201673 | 100 | 75 (75) | 75.3 ± 7.5 | Lower extremity OA | No | K-L score: 2.4 ± 1.1 |
Somers et al. 201278 | 232 | 184 (79) | 58.0 ± 10.4 | Knee OA | No | None |
Taglietti et al. 201836 | 60 | 41 (68) | 68.3 ± 4.8 | Knee OA | No | None |
Tak et al. 200579 | 109 | 64 (68) | I: 67.4 ± 7.6 C: 68.9 (SD not provided) | Hip OA | No | None |
Walsh et al. 202080 | 349 | 216 (62) | I: 66.3 ± 8.1 C: 66.5 ± 8.4 | % of sample Hip/knee only I: 57; C: 59 Lower back pain (LBP): I: 59; C: 56 Hip/knee and LBP: I: 65; C: 66 | No | None |
Yip et al. 200881 | 95 | 81 (85) | I: 64.8 ± 10.1 C: 63.4 ± 10.7 | Knee OA | No | OA condition duration in years mean ± SD I: 8.0 ± 5.9; C: 6.7 ± 6.0 |
Zhang et al. 202274 | 50 | 37 (74) | I: 55.8 ± 8.4 C: 53.4 ± 10.7 | Knee OA | No | None |